Other Terms of Separation Agreement Incorporated Herein. All other terms of the Separation Agreement to the extent not inconsistent with the terms of this Second Release are hereby incorporated in this Second Release as though fully stated herein and apply with equal force to this Second Release, including, without limitation, the provisions on Arbitration, Governing Law, and Attorneys’ Fees.
Other Terms of Separation Agreement Incorporated Herein. All other terms of the Separation Agreement to the extent not inconsistent with the terms of this Second Release are hereby incorporated in this Second Release as though fully stated herein and apply with equal force to this Second Release, including, without limitation, the provisions on Arbitration, Governing Law, and Attorneys’ Fees. Dated: Name: J Xxxxxxx Xxxxxx Dated: Wxxxxxx (Bxxx) Mxxxxxx Re: Amendment to Transition and Separation Agreement Dear Bxxx: This letter (the “Amendment”) serves to partially amend the terms of your July 27, 2023 Transition and Separation Agreement by Energous Corporation (the “Company”), which is attached hereto as Exhibit 1 (the “Separation Agreement”). Effective as of the Effective Date (defined below), you and the Company hereby agree as follows:
Other Terms of Separation Agreement Incorporated Herein. All other terms of the Transitional Employment Agreement, to the extent not inconsistent with the terms of this Second Release, are hereby incorporated in this Release as though fully stated herein and apply with equal force to this Release, including, without limitation, the provisions on Arbitration, No Admission of Liability, Confidentiality, Nondisparagement, Governing Law and Attorneys’ Fees.
Other Terms of Separation Agreement Incorporated Herein. All other terms of the Separation Agreement to the extent not inconsistent with the terms of this Second Release are hereby incorporated in this Second Release as though fully stated herein and apply with equal force to this Second Release, including, without limitation, the provisions on Arbitration, Governing Law, Section 409A Savings Clause and Attorneys’ Fees. Dated:____________________ ________________________________ Name: Xxxxx Xxxxxx Title: CEO For the Company and in his individual capacity Dated:____________________ ________________________________ Xxxxx Xxxx This Consulting Agreement (“Agreement”) is entered into as of January 2, 2016 (the “Effective Date”), between Green Dot Corporation (“Company”) and Xxxxx Xxxx (“Consultant”). Company and Consultant desire to have Consultant perform services for Company, subject to and in accordance with the terms and conditions of this Agreement.
Other Terms of Separation Agreement Incorporated Herein. All other terms of the Separation Agreement to the extent not inconsistent with the terms of this Second Release are hereby incorporated in this Second Release as though fully stated herein and apply with equal force to this Second Release, including, without limitation, the provisions on Nondisparagement, Arbitration, Governing Law, and Attorneys’ Fees. Dated: 1/14/2016 /s/ Xxxxxx Xxxxxxxx Name: Title: For the Company Dated: 1/7/2016 /s/ Xxxxxxxx Xxx Xxxxxxxx Xxx, M.D., Ph.D., X.X.Xx. THIS CONSULTING AGREEMENT (this “Agreement”) is entered into as of January 1, 2016 (the “Effective Date”) between Loxo Oncology, Inc., a Delaware corporation with its principal place of business at 0 Xxxxxxxx Xxxxxx, Xxxxx 0000, Xxxxxxxx, XX (“Company”) and Green Duck Punch LLC (“Consultant”). Company desires to retain Consultant to perform certain consulting activities as described below, and Consultant desires to serve as a consultant to Company and perform such activities under the terms of this Agreement.
Other Terms of Separation Agreement Incorporated Herein. All other terms of the Separation Agreement to the extent not inconsistent with the terms of this First Release are hereby incorporated in this First Release as though fully stated herein and apply with equal force to this First Release, including, without limitation the provisions on Arbitration, Governing Law, and Attorneys’ Fees. Dated: Name: Title: Dated: Xxxxxxxx Xxxxxx This Consulting Agreement (“Agreement”) is entered into as of April 1, 2013 (the “Effective Date”), between OncoGenex Pharmaceuticals, Inc., a corporation (“Company”), and Xxxxxxxx X. Xxxxxx, a sole proprietorship, Unified Business Identifier number 000-000-000 (“Consultant”). Company and Consultant desire to have Consultant perform services for Company, subject to and in accordance with the terms and conditions of this Agreement. THEREFORE, the parties agree as follows:
Other Terms of Separation Agreement Incorporated Herein. All other terms of the Separation Agreement to the extent not inconsistent with the terms of this Second Release are hereby incorporated in this Second Release as though fully stated herein and apply with equal force to this Second Release, including, without limitation, the provisions on Nondisparagement, Arbitration, Governing Law, and Attorneys’ Fees. Dated: September 30, 2015 /s/ Dxxxx X. Xxxxxxx Name: Dxxxx X. Xxxxxxx Title: Chief Executive Officer For the Company Dated: September 30, 2015 /s/ Cxxxxxxxxxx X. Xxxx Cxxxxxxxxxx X. Xxxx This Technology Assignment Agreement (this “Agreement”) is made and entered into effective as of April 2, 2006 by and between Marin Software Incorporated, a Delaware corporation (the “Company”), and Cxxxxxxxxxx Xxxx, a resident of California (the “Assignor”).
Other Terms of Separation Agreement Incorporated Herein. All other terms of the Separation Agreement to the extent not inconsistent with the terms of this Second Release are hereby incorporated in this Second Release as though fully stated herein and apply with equal force to this Second Release, including, without limitation, the provisions on Nondisparagement, Arbitration, Governing Law, and Attorneys’ Fees. Dated: 1/14/2016 /s/ Xxxxxx Xxxxxxxx Name: Title: For the Company Dated: 1/7/2016 /s/ Xxxxxxxx Xxx Xxxxxxxx Xxx, M.D., Ph.D., X.X.Xx. [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. EXHIBIT B EMPLOYEE INVENTION ASSIGNMENT AND CONFIDENTIALITY AGREEMENT EXHIBIT C CONSULTANT AGREEMENT [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is entered into as of January 1, 2016 (the “Effective Date”) between Loxo Oncology, Inc., a Delaware corporation with its principal place of business at 0 Xxxxxxxx Xxxxxx, Xxxxx 0000, Xxxxxxxx, XX (“Company”) and Green Duck Punch LLC (“Consultant”). Company desires to retain Consultant to perform certain consulting activities as described below, and Consultant desires to serve as a consultant to Company and perform such activities under the terms of this Agreement.
Other Terms of Separation Agreement Incorporated Herein. All other terms of the Separation Agreement to the extent not inconsistent with the terms of this Second Release are hereby incorporated in this Second Release as though fully stated herein and apply with equal force to this Second Release, including, without limitation, the provisions on Arbitration, Governing Law, and Attorneys’ Fees. Dated:____________________ ________________________________ Title: Chief Executive Officer Dated:____________________ ________________________________ Xxxx Xxxxxxx XXXX XXXXXXX /s/ Xxxx Xxxxxxx Signature XXXX.XXX HOLDINGS, INC. a Delaware corporation By: /s/ Xxxx Xxxxxxx Name: Xxxx Xxxxxxx Title: Chief Executive Officer By: /s/ Xxxxxxxxxx Xxxxx Name: Xxxxxxxxxx Xxxxx Title: SVP, Human Resources /s/ Xxxx Xxxxxxx Signature Name (Please Print): Xxxx Xxxxxxx X No inventions, improvements, or original works of authorship Additional sheets attached Signature of Employee: /s/ Xxxx Xxxxxxx Print Name of Employee: Xxxx Xxxxxxx Date: July 16, 2021 Xxxx Xxxxxxx
Other Terms of Separation Agreement Incorporated Herein. All other terms of the Separation Agreement to the extent not inconsistent with the terms of this First Release are hereby incorporated in this First Release as though fully stated herein and apply with equal force to this First Release, including, without limitation the provisions on Arbitration, Governing Law, and Attorneys’ Fees. Dated: Name: Title: Dated: Xxxxxxxx Xxxxxx EXHIBIT D CONSULTING AGREEMENT CONSULTING AGREEMENT This Consulting Agreement (“Agreement”) is entered into as of April 1, 2013 (the “Effective Date”), between OncoGenex Pharmaceuticals, Inc., a corporation (“Company”), and Xxxxxxxx X. Xxxxxx, a sole proprietorship, Unified Business Identifier number 000-000-000 (“Consultant”). Company and Consultant desire to have Consultant perform services for Company, subject to and in accordance with the terms and conditions of this Agreement. THEREFORE, the parties agree as follows:
